FDA Inspection
Eurofins Lancaster Laboratories, IncEurofins Lancaster Laboratories, Inc – FDA Inspection, Nov 4, 2016
Record Details
This FDA Inspection record concerns Eurofins Lancaster Laboratories, Inc, with an inspection on November 4, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 19955c49-0273-4c87-b3d7-7aa5f1cbf109
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1001348
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins Lancaster Laboratories, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2025 | VAI | Detroit District Office | Drug Quality Assurance |
| December 10, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 1, 2014 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Eurofins Lancaster Laboratories, Inc
- FDA Inspection 1272016 - 2025-05-30
- FDA Inspection 1160560 - 2021-12-10
- FDA Inspection 1080439 - 2019-01-23
- FDA Inspection 1045298 - 2018-02-23
- FDA Inspection 889635 - 2014-08-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.